show help

Schols D

Author page

This page provides a summary of the entries in Polbase associated with this author.

The publication history graph presents the number of publications in Polbase by this author over time.

The polymerase chart indicates which polymerases this author has published on.

Polbase automatically discovers many polymerase papers as they are published. Some relevant papers are not included because the algorithm is designed to reduce background. Please contribute to polbase by adding your missing DNA polymerase papers.

Help icons:

The show help symbol in the upper-right corner of the page links to this help text. The question mark icon is used everywhere to indicate that help is available.

Missing references?


Title Authors Year Journal
A Multi-targeted Drug Candidate with Dual Anti-HIV and Anti-HSV Activity. Schols D 2013 PLoS pathogens
New Nitrogen Containing Substituents at the Indole-2-carboxamide Yield High Potent and Broad Spectrum Indolylarylsulfone HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors. Schols D 2012 Journal of medicinal chemistry
Indolylarylsulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors: new cyclic substituents at indole-2-carboxamide. Schols D 2011 Journal of medicinal chemistry
Therapeutic strategies towards HIV-1 infection in macrophages. Schols D 2006 Antiviral research
Marked depletion of glycosylation sites in HIV-1 gp120 under selection pressure by the mannose-specific plant lectins of Hippeastrum hybrid and Galanthus nivalis. Schols D 2005 Molecular pharmacology
Pyridine N-oxide derivatives: unusual anti-HIV compounds with multiple mechanisms of antiviral action. Schols D 2005 The Journal of antimicrobial chemotherapy
CADA, a novel CD4-targeted HIV inhibitor, is synergistic with various anti-HIV drugs in vitro. Schols D 2004 AIDS (London, England)
Development of a cell-based enzyme-linked immunosorbent assay for high-throughput screening of HIV type 1 entry inhibitors targeting the coreceptor CXCR4. Schols D 2003 AIDS research and human retroviruses
2-Chloro-3-pyridin-3-yl-5,6,7,8-tetrahydroindolizine-1-carboxamide (CMV423), a new lead compound for the treatment of human cytomegalovirus infections. Schols D 2002 Antiviral research
Inhibition of HIV infection by CXCR4 and CCR5 chemokine receptor antagonists. Schols D 2001 Antiviral chemistry & chemotherapy
Polyanionic (i.e., polysulfonate) dendrimers can inhibit the replication of human immunodeficiency virus by interfering with both virus adsorption and later steps (reverse transcriptase/integrase) in the virus replicative cycle. Schols D 2000 Molecular pharmacology
9-(2-Phosphonylmethoxyethyl)adenine induces tumor cell differentiation or cell death by blocking cell cycle progression through the S phase. Schols D 1999 Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research
SRR-SB3, a disulfide-containing macrolide that inhibits a late stage of the replicative cycle of human immunodeficiency virus. Schols D 1997 Antimicrobial agents and chemotherapy
Highly favorable antiviral activity and resistance profile of the novel thiocarboxanilide pentenyloxy ether derivatives UC-781 and UC-82 as inhibitors of human immunodeficiency virus type 1 replication. Schols D 1996 Molecular pharmacology
New tetrahydroimidazo[4,5,1-jk][1,4]-benzodiazepin-2(1H)-one and -thione derivatives are potent inhibitors of human immunodeficiency virus type 1 replication and are synergistic with 2',3'-dideoxynucleoside analogs. Schols D 1994 Antimicrobial agents and chemotherapy
Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents. Schols D 1992 Molecular pharmacology
2',5'-Bis-O-(tert-butyldimethylsilyl)-3'-spiro-5''-(4''-amino-1'',2''- oxathiole-2'',2'-dioxide)pyrimidine (TSAO) nucleoside analogues: highlyselective inhibitors of human immunodeficiency virus type 1 that are targeted at the viral reverse transcriptase. Schols D 1992 Proceedings of the National Academy of Sciences of the United States of America
Anti-human immunodeficiency virus effects of cationic metalloporphyrin-ellipticine complexes. Schols D 1992 Biochemical pharmacology
Synthesis and anti-HIV activities of low molecular weight aurintricarboxylic acid fragments and related compounds. Schols D 1991 Journal of medicinal chemistry
Preparation and anti-HIV activities of aurintricarboxylic acid fractions and analogues: direct correlation of antiviral potency with molecular weight. Schols D 1991 Journal of medicinal chemistry
Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative. Schols D 1989 Biochemical and biophysical research communications
Selective activity of several cholic acid derivatives against human immunodeficiency virus replication in vitro. Schols D 1989 Journal of acquired immune deficiency syndromes
Flow cytometric method to demonstrate whether anti-HIV-1 agents inhibit virion binding to T4+ cells. Schols D 1989 Journal of acquired immune deficiency syndromes
Fuchsin acid selectively inhibits human immunodeficiency virus (HIV) replication in vitro. Schols D 1988 Biochemical and biophysical research communications

Using Polbase tables:


Tables may be sorted by clicking on any of the column titles. A second click reverses the sort order. <Ctrl> + click on the column titles to sort by more than one column (e.g. family then name).


It is also possible to filter the table by typing into the search box above the table. This will instantly hide lines from the table that do not contain your search text.